Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
CDTTW
CDT EQUITY INC.
NASDAQ
$0.01
▲ UP 1.57% (0.00)

KEY STATISTICS

Market Cap$21.02 K
52w High$0.01
52w Low$0.01
Dividend Yield—
Frequency—
P/E—
Volume36.86K
Shares Out.1.63M

COMPANY

LEADERSHIP

James Bligh
CHIEF EXECUTIVE
James Bligh

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 28, 2022
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
4

PRICE

$0.01 ▲ UP 1.57% (+$0.00)
$0.01$0.01$0.01$0.01$0.01$0.01$0.01$0.01$0.0110:42 AM11:34 AM12:27 PM1:19 PM2:12 PM3:04 PM3:57 PM0.01

About CDT Equity Inc.

https://www.cdtequity.com ↗

CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.

INDUSTRY

Biotechnology

A SERVICE CDT EQUITY INC. IS KNOWN FOR

Drug Development and Licensing of Therapeutic Assets

CDT Equity Inc. is a clinical-stage biopharmaceutical company that acquires, develops, and out-licenses deprioritized drug candidates, including AZD1656 and AZD5904, for autoimmune diseases and male infertility.

COMPETITORS

COMPETITOR
AIXC COMPARE
APVO COMPARE
BMRA COMPARE
DWTX COMPARE
GNPX COMPARE

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book5
Overall Score3

INSIDER TRADES

★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Regan Andrew
Purchase · 5.4M shares
2026-08-28
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Regan Andrew
Purchase · 5.4M shares
2026-07-30
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Regan Andrew
Sale · 290 shares
2026-08-28
★
10 PERCENT OWNER
Taylor Mark Andrew
Sale · 5.0K shares
2026-06-18

SECTORS PEERS

PEERPRICE
AKTX$9.16COMPARE
REVB$0.93COMPARE
DRMA$1.16COMPARE
BDRX$0.73COMPARE
XAGE$0.17COMPARE
PPBT$1.44COMPARE
PBM$6.63COMPARE
VRPX$0.01COMPARE